Clinical-stage specialty pharmaceutical company, Savara, Inc. today announced the initiation of the AVAIL study, a Phase III, randomized, double-blind, placebo-controlled study of AeroVanc (vancomycin...

Researchers at the National Institute of Standards and Technology (NIST) have demonstrated a potential new tactic for rapidly determining whether an antibiotic combats a given infection, thus hastening...

According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhea infection...

Atara Biotherapeutics, Inc. announced that ATA230 was granted orphan drug designation for the treatment of cytomegalovirus (CMV) viremia and disease in immunocompromised patients by the U.S. Food and...

A collaborative team of scientists, led by a group at The University of Texas Medical Branch at Galveston, have successfully protected nonhuman primates against one of the most deadly viruses in the world,...

The U.S. Food and Drug Administration Tuesday approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria....

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United...

The World Health Organisation (WHO) has estimated that 700,000 people around the world die annually from drug resistant infections. It also listed drug resistant gonorrhea, a sexually transmitted disease...

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir)to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with...

Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson’s disease while providing better symptom relief to potentially hundreds of thousands of...